BJDX Bluejay Diagnostics, Inc.: institutional ownership and insider trading
9 funds reported holding $260K of Bluejay Diagnostics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $189K, with 5 new positions and 3 funds selling out; over the last 12 months insiders bought $222K and sold $48.9K on the open market.
BJDX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$2.32M, EPS -1.12
- Quarter ended Mar 31, 2026: revenue n/a, net income −$1.92M, EPS -1.95
- Quarter ended Dec 31, 2025: revenue n/a, net income −$1.43M, EPS 4.86
- Quarter ended Sep 30, 2025: revenue n/a, net income −$1.60M, EPS -1.01
Largest institutional holders of BJDX
- ARMISTICE CAPITAL, LLC — $157K
- HEIGHTS CAPITAL MANAGEMENT, INC — $42.5K
- BOOTHBAY FUND MANAGEMENT, LLC — $32.6K
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $12.4K
- VANGUARD FIDUCIARY TRUST CO — $12.3K
- Tower Research Capital LLC (TRC) — $2.29K
- SBI Securities Co., Ltd. — $258
- L1 Global Manager Pty Ltd — $144
- Caitong International Asset Management Co., Ltd — $1
Recent BJDX insider trades
- Jul 10, 2026: Hrt Financial Lp sold 34,938 shares ($48.9K)
- Jul 9, 2026: Hrt Financial Lp bought 64,047 shares ($96.7K)
- Mar 14, 2026: Wurth Douglas Clark bought 12,500 shares ($25.0K)
- Mar 14, 2026: Dey Indranil bought 12,500 shares ($25.0K)
5%+ owners
- Armistice Capital, LLC: 10.0% (Schedule 13G, filed Aug 14, 2026)
- Ayrton Capital LLC: 10.0% (Schedule 13G, filed Aug 13, 2026)
- Mitchell P. Kopin: 10.0% (Schedule 13G, filed Jun 5, 2026)
Who owns the most BJDX stock?
The largest institutional holders of Bluejay Diagnostics, Inc. in the latest 13F filings are ARMISTICE CAPITAL, LLC ($157K), HEIGHTS CAPITAL MANAGEMENT, INC ($42.5K), BOOTHBAY FUND MANAGEMENT, LLC ($32.6K).
Are insiders buying or selling BJDX?
Over the last 12 months insiders bought $222K and sold $48.9K of Bluejay Diagnostics, Inc. stock on the open market (SEC Form 4).